Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Short term Debt: 2017-2024

Historic Short term Debt for UNITED THERAPEUTICS (UTHR) over the last 5 years, with Dec 2024 value amounting to $300.0 million.

  • UNITED THERAPEUTICS's Short term Debt fell 50.00% to $200.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $200.0 million, marking a year-over-year decrease of 50.00%. This contributed to the annual value of $300.0 million for FY2024, which is 25.00% down from last year.
  • As of FY2024, UNITED THERAPEUTICS's Short term Debt stood at $300.0 million, which was down 25.00% from $400.0 million recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Short term Debt registered a high of $400.0 million during FY2023, and its lowest value of $300.0 million during FY2024.
  • For the 2-year period, UNITED THERAPEUTICS's Short term Debt averaged around $350.0 million, with its median value being $350.0 million (2023).
  • Data for UNITED THERAPEUTICS's Short term Debt shows a maximum YoY declined of 25.00% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows UNITED THERAPEUTICS's Short term Debt stood at $400.0 million in 2023, then fell by 25.00% to $300.0 million in 2024.